학술논문
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer
Document Type
Article
Author
Source
In: British Journal of Cancer . (British Journal of Cancer, 27 July 2023, 129(1):38-45)
Subject
Language
English
ISSN
15321827
00070920
00070920